tiprankstipranks
Alaunos Therapeutics (TCRT)
NASDAQ:TCRT
US Market

Alaunos Therapeutics (TCRT) Income Statement

Compare
675 Followers

Alaunos Therapeutics Income Statement

Last quarter (Q3 2024), Alaunos Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Alaunos Therapeutics's net income was $-1.13M. See Alaunos Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 5.00K$ 2.92M$ 398.00K$ 0.00$ 0.00
Gross Profit
$ -4.80M$ 163.00K$ -342.00K$ -1.13M$ -629.00K
Operating Expenses
$ 29.47M$ 38.16M$ 77.21M$ 80.36M$ 57.86M
Depreciation and Amortization
$ 2.31M$ 2.76M$ 2.60M$ 1.13M$ 629.00K
EBITDA
$ -30.90M$ -31.82M$ -74.97M$ -78.85M$ -117.17M
Operating Income
$ -34.27M$ -35.10M$ -77.55M$ -80.36M$ 2.26M
Other Income/Expenses
$ -873.00K$ -2.63M$ -1.20M$ 385.00K$ -59.94M
Pretax Income
$ -35.14M$ -37.73M$ -78.75M$ -79.98M$ -117.80M
Net Income
$ -35.14M$ -37.60M$ -76.89M$ -78.85M$ -177.92M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -21.97$ -25.97$ -53.80$ -56.42$ -158.90
Diluted EPS
$ -21.97$ -25.97$ -53.80$ -56.42$ -158.90
Weighted Average Shares Outstanding
1.60M 1.45M 1.43M 1.40M 1.12M
Weighted Average Shares Outstanding (Diluted)
1.60M 1.45M 1.43M 1.40M 1.12M
Currency in USD

Alaunos Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis